 Jennie Buchanan
Concepts (189)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cocaine | 6 | 2012 | 173 | 1.550 |
Why?
| | Levamisole | 4 | 2012 | 19 | 1.390 |
Why?
| | Drug Contamination | 4 | 2012 | 52 | 1.130 |
Why?
| | Sex Offenses | 7 | 2025 | 200 | 0.990 |
Why?
| | Emergency Medicine | 4 | 2023 | 246 | 0.980 |
Why?
| | Emergency Service, Hospital | 13 | 2025 | 2193 | 0.960 |
Why?
| | Agranulocytosis | 3 | 2012 | 32 | 0.780 |
Why?
| | Methylene Chloride | 1 | 2021 | 5 | 0.690 |
Why?
| | Dopamine Uptake Inhibitors | 2 | 2011 | 60 | 0.680 |
Why?
| | Argyria | 1 | 2020 | 4 | 0.660 |
Why?
| | Silver | 1 | 2020 | 38 | 0.640 |
Why?
| | Skin Diseases | 1 | 2021 | 147 | 0.600 |
Why?
| | Resuscitation | 1 | 2020 | 283 | 0.560 |
Why?
| | Survivors | 4 | 2025 | 504 | 0.540 |
Why?
| | Occupational Exposure | 1 | 2021 | 349 | 0.510 |
Why?
| | Toxicology | 3 | 2025 | 44 | 0.500 |
Why?
| | Internship and Residency | 4 | 2025 | 1240 | 0.500 |
Why?
| | Lithium Compounds | 1 | 2015 | 11 | 0.480 |
Why?
| | Stress Disorders, Post-Traumatic | 5 | 2025 | 861 | 0.470 |
Why?
| | Tea Tree Oil | 1 | 2015 | 2 | 0.460 |
Why?
| | Exanthema | 2 | 2012 | 81 | 0.450 |
Why?
| | Antidotes | 3 | 2014 | 142 | 0.450 |
Why?
| | Nausea | 2 | 2012 | 111 | 0.440 |
Why?
| | Pediatrics | 2 | 2020 | 1100 | 0.440 |
Why?
| | Clinical Competence | 3 | 2025 | 1205 | 0.430 |
Why?
| | Pulmonary Surfactants | 1 | 2015 | 105 | 0.430 |
Why?
| | Flecainide | 1 | 2012 | 7 | 0.380 |
Why?
| | Sulfhydryl Reagents | 1 | 2012 | 12 | 0.380 |
Why?
| | Tachycardia | 1 | 2012 | 55 | 0.370 |
Why?
| | Antinematodal Agents | 1 | 2012 | 6 | 0.370 |
Why?
| | Acute Generalized Exanthematous Pustulosis | 1 | 2011 | 4 | 0.370 |
Why?
| | Arsenicals | 1 | 2012 | 30 | 0.370 |
Why?
| | Pharmacy | 1 | 2012 | 32 | 0.370 |
Why?
| | Drug Compounding | 1 | 2012 | 104 | 0.360 |
Why?
| | Drug Overdose | 4 | 2025 | 357 | 0.360 |
Why?
| | Cephalexin | 1 | 2011 | 14 | 0.360 |
Why?
| | Crime | 2 | 2011 | 60 | 0.360 |
Why?
| | Chickenpox | 1 | 2012 | 81 | 0.360 |
Why?
| | Sulfides | 1 | 2012 | 86 | 0.350 |
Why?
| | Respiratory Insufficiency | 1 | 2015 | 325 | 0.350 |
Why?
| | Renal Dialysis | 1 | 2015 | 457 | 0.350 |
Why?
| | Skin Diseases, Vascular | 1 | 2011 | 9 | 0.350 |
Why?
| | Nasal Septum | 1 | 2011 | 25 | 0.350 |
Why?
| | Anthelmintics | 1 | 2011 | 11 | 0.350 |
Why?
| | Suicide, Attempted | 2 | 2012 | 394 | 0.350 |
Why?
| | Facial Injuries | 1 | 2011 | 23 | 0.340 |
Why?
| | Hematoma | 1 | 2011 | 54 | 0.340 |
Why?
| | Depression | 2 | 2024 | 1508 | 0.340 |
Why?
| | Foreign Bodies | 2 | 2011 | 107 | 0.330 |
Why?
| | Vasculitis | 1 | 2011 | 68 | 0.330 |
Why?
| | Ethylene Glycol | 1 | 2010 | 15 | 0.330 |
Why?
| | Education, Medical | 2 | 2025 | 271 | 0.320 |
Why?
| | Cocaine-Related Disorders | 1 | 2011 | 136 | 0.310 |
Why?
| | Adjuvants, Immunologic | 1 | 2011 | 240 | 0.310 |
Why?
| | Skin | 4 | 2020 | 765 | 0.300 |
Why?
| | Faculty, Medical | 2 | 2023 | 296 | 0.290 |
Why?
| | Humans | 41 | 2025 | 141754 | 0.290 |
Why?
| | Pneumonia, Viral | 1 | 2012 | 374 | 0.260 |
Why?
| | Pyrazoles | 1 | 2010 | 482 | 0.250 |
Why?
| | Crime Victims | 2 | 2025 | 130 | 0.250 |
Why?
| | Adult | 20 | 2025 | 39391 | 0.240 |
Why?
| | Referral and Consultation | 2 | 2025 | 799 | 0.230 |
Why?
| | Male | 20 | 2025 | 70179 | 0.230 |
Why?
| | Police | 1 | 2025 | 45 | 0.230 |
Why?
| | Education, Distance | 1 | 2025 | 56 | 0.220 |
Why?
| | Benzodiazepines | 1 | 2025 | 162 | 0.210 |
Why?
| | Hyperhidrosis | 1 | 2023 | 5 | 0.210 |
Why?
| | Curriculum | 2 | 2021 | 1039 | 0.210 |
Why?
| | Mydriasis | 1 | 2023 | 10 | 0.210 |
Why?
| | Urinary Retention | 1 | 2023 | 22 | 0.200 |
Why?
| | Fentanyl | 1 | 2024 | 120 | 0.200 |
Why?
| | Adenosine Monophosphate | 1 | 2024 | 73 | 0.200 |
Why?
| | Middle Aged | 16 | 2025 | 34647 | 0.200 |
Why?
| | Young Adult | 11 | 2025 | 13749 | 0.200 |
Why?
| | Simulation Training | 1 | 2025 | 127 | 0.200 |
Why?
| | Alanine | 1 | 2024 | 158 | 0.200 |
Why?
| | Anti-Bacterial Agents | 1 | 2011 | 1866 | 0.170 |
Why?
| | Prospective Studies | 8 | 2025 | 7777 | 0.170 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2023 | 258 | 0.170 |
Why?
| | Compartment Syndromes | 1 | 2021 | 31 | 0.170 |
Why?
| | Analgesics, Opioid | 2 | 2025 | 1123 | 0.160 |
Why?
| | Problem Solving | 1 | 2020 | 156 | 0.150 |
Why?
| | Colubridae | 1 | 2018 | 9 | 0.150 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2023 | 408 | 0.150 |
Why?
| | Female | 21 | 2025 | 75943 | 0.150 |
Why?
| | Snake Venoms | 1 | 2018 | 22 | 0.150 |
Why?
| | Snake Bites | 1 | 2018 | 23 | 0.150 |
Why?
| | Healthcare Disparities | 1 | 2025 | 673 | 0.140 |
Why?
| | Pediatricians | 1 | 2020 | 131 | 0.140 |
Why?
| | Educational Status | 1 | 2020 | 464 | 0.140 |
Why?
| | Emergency Medical Services | 2 | 2024 | 650 | 0.140 |
Why?
| | Poisoning | 2 | 2015 | 120 | 0.130 |
Why?
| | Eating | 1 | 2020 | 392 | 0.130 |
Why?
| | Fellowships and Scholarships | 1 | 2021 | 323 | 0.130 |
Why?
| | Anxiety | 2 | 2024 | 1090 | 0.130 |
Why?
| | Thrombocytopenia | 1 | 2018 | 208 | 0.130 |
Why?
| | Lithium Carbonate | 1 | 2015 | 6 | 0.120 |
Why?
| | Deglutition | 1 | 2015 | 71 | 0.110 |
Why?
| | Critical Illness | 1 | 2020 | 837 | 0.110 |
Why?
| | Tertiary Care Centers | 1 | 2015 | 178 | 0.100 |
Why?
| | Naloxone | 2 | 2025 | 129 | 0.100 |
Why?
| | Acetylcysteine | 1 | 2014 | 144 | 0.100 |
Why?
| | Administration, Oral | 2 | 2014 | 803 | 0.100 |
Why?
| | Alanine Transaminase | 2 | 2024 | 150 | 0.100 |
Why?
| | Narcotic Antagonists | 2 | 2025 | 192 | 0.100 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2014 | 138 | 0.100 |
Why?
| | United States | 5 | 2025 | 15310 | 0.090 |
Why?
| | Therapeutic Irrigation | 1 | 2012 | 79 | 0.090 |
Why?
| | Vasculitis, Leukocytoclastic, Cutaneous | 1 | 2011 | 8 | 0.090 |
Why?
| | Veterinary Drugs | 1 | 2011 | 2 | 0.090 |
Why?
| | Acetaminophen | 1 | 2014 | 264 | 0.090 |
Why?
| | False Negative Reactions | 1 | 2011 | 61 | 0.090 |
Why?
| | Leukoencephalopathies | 1 | 2011 | 19 | 0.090 |
Why?
| | Infant | 3 | 2015 | 9843 | 0.090 |
Why?
| | Ear, External | 1 | 2011 | 21 | 0.090 |
Why?
| | Hospitals, Pediatric | 1 | 2015 | 532 | 0.090 |
Why?
| | Prevalence | 2 | 2024 | 2799 | 0.090 |
Why?
| | Fluid Therapy | 1 | 2012 | 142 | 0.090 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2011 | 136 | 0.090 |
Why?
| | Fever | 1 | 2012 | 308 | 0.080 |
Why?
| | Immunoassay | 1 | 2011 | 113 | 0.080 |
Why?
| | Crack Cocaine | 1 | 2010 | 7 | 0.080 |
Why?
| | Hospitals, Urban | 1 | 2011 | 137 | 0.080 |
Why?
| | Leukopenia | 1 | 2010 | 31 | 0.080 |
Why?
| | Half-Life | 1 | 2010 | 146 | 0.080 |
Why?
| | Necrosis | 1 | 2011 | 249 | 0.080 |
Why?
| | Injections, Intravenous | 1 | 2010 | 202 | 0.080 |
Why?
| | Adolescent | 7 | 2025 | 22130 | 0.080 |
Why?
| | Radiography | 1 | 2012 | 844 | 0.080 |
Why?
| | Reproducibility of Results | 2 | 2024 | 3356 | 0.080 |
Why?
| | Blood Chemical Analysis | 1 | 2010 | 110 | 0.080 |
Why?
| | Accidents, Traffic | 1 | 2011 | 190 | 0.080 |
Why?
| | Leukocyte Count | 1 | 2010 | 328 | 0.080 |
Why?
| | Neutropenia | 1 | 2010 | 157 | 0.080 |
Why?
| | HIV Infections | 1 | 2024 | 3022 | 0.080 |
Why?
| | Intestines | 1 | 2012 | 357 | 0.070 |
Why?
| | Infant, Newborn | 1 | 2020 | 6289 | 0.070 |
Why?
| | Bone Marrow | 1 | 2010 | 302 | 0.070 |
Why?
| | Pharmacy Service, Hospital | 1 | 2009 | 87 | 0.070 |
Why?
| | Time Factors | 3 | 2020 | 6966 | 0.070 |
Why?
| | Aged, 80 and over | 1 | 2020 | 7923 | 0.070 |
Why?
| | Pain | 2 | 2024 | 781 | 0.070 |
Why?
| | Treatment Outcome | 1 | 2021 | 11181 | 0.060 |
Why?
| | India | 1 | 2025 | 208 | 0.060 |
Why?
| | Missouri | 1 | 2024 | 60 | 0.050 |
Why?
| | Pennsylvania | 1 | 2024 | 134 | 0.050 |
Why?
| | Glycopyrrolate | 1 | 2023 | 2 | 0.050 |
Why?
| | Cohort Studies | 2 | 2024 | 5815 | 0.050 |
Why?
| | Piperidines | 1 | 2024 | 218 | 0.050 |
Why?
| | Educational Measurement | 1 | 2025 | 319 | 0.050 |
Why?
| | Colorado | 2 | 2024 | 4629 | 0.050 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2024 | 561 | 0.050 |
Why?
| | Buprenorphine | 1 | 2025 | 179 | 0.040 |
Why?
| | Arousal | 1 | 2022 | 160 | 0.040 |
Why?
| | Residence Characteristics | 1 | 2024 | 368 | 0.040 |
Why?
| | Computer Simulation | 1 | 2025 | 1015 | 0.040 |
Why?
| | Students, Medical | 1 | 2025 | 369 | 0.040 |
Why?
| | Needs Assessment | 1 | 2023 | 385 | 0.040 |
Why?
| | Orbit | 1 | 2021 | 71 | 0.040 |
Why?
| | Pediatric Emergency Medicine | 1 | 2020 | 24 | 0.040 |
Why?
| | Medical Staff, Hospital | 1 | 2020 | 82 | 0.040 |
Why?
| | Blister | 1 | 2018 | 40 | 0.040 |
Why?
| | Surveys and Questionnaires | 2 | 2023 | 5974 | 0.040 |
Why?
| | Risk Factors | 2 | 2024 | 10482 | 0.040 |
Why?
| | Edema | 1 | 2018 | 131 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2025 | 2938 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2024 | 747 | 0.030 |
Why?
| | Focus Groups | 1 | 2020 | 572 | 0.030 |
Why?
| | Guideline Adherence | 1 | 2020 | 566 | 0.030 |
Why?
| | Registries | 1 | 2024 | 2144 | 0.030 |
Why?
| | Retrospective Studies | 3 | 2024 | 16374 | 0.030 |
Why?
| | Pandemics | 1 | 2023 | 1656 | 0.030 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2015 | 96 | 0.030 |
Why?
| | Patient Readmission | 1 | 2020 | 708 | 0.030 |
Why?
| | Poison Control Centers | 1 | 2015 | 79 | 0.030 |
Why?
| | Length of Stay | 1 | 2020 | 1263 | 0.030 |
Why?
| | Patient Acceptance of Health Care | 1 | 2020 | 881 | 0.030 |
Why?
| | Administration, Intravenous | 1 | 2014 | 161 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 5697 | 0.020 |
Why?
| | Pregnancy | 1 | 2023 | 7092 | 0.020 |
Why?
| | Body Weight | 1 | 2014 | 997 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2014 | 2064 | 0.020 |
Why?
| | Watchful Waiting | 1 | 2010 | 85 | 0.020 |
Why?
| | Drug Storage | 1 | 2009 | 53 | 0.020 |
Why?
| | Drug Utilization | 1 | 2009 | 169 | 0.020 |
Why?
| | Child | 2 | 2020 | 22414 | 0.020 |
Why?
| | Evidence-Based Medicine | 1 | 2009 | 750 | 0.010 |
Why?
| | Child, Preschool | 1 | 2015 | 11512 | 0.010 |
Why?
| | Animals | 1 | 2018 | 37749 | 0.010 |
Why?
|
|
Buchanan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|